Remove Funding Remove Marketing Remove Pricing Remove San Diego
article thumbnail

San Diego's Seismic Snags $100M, Joins Unicorns

socalTECH

San Diego-based Seismic , a developer of sales and marketing software, has raised $100M more in a funding round, which values the company at $1 billion, the company said on Tuesday. The funding round came from Lightspeed Venture Partners, T. READ MORE>>.

San Diego 113
article thumbnail

TuSimple Prices IPO, Starts Trading Today

socalTECH

San Diego-based TuSimple priced its IPO last night, saying that it will sell 33,783,783 shares of its Class A common stock at the price of $40.00 The company will begin trading this morning on the Nasdaq Global Select Market as TSP. Composite Capital Master Fund, and Navistar.

Pricing 113
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How long can Zuckerberg afford to bankroll the AR/VR market?

TechCrunch LA

Last week, we talked about about the “de-stonkifying” of the market. The company’s stock tanked by more than 26 percent, representing a $230 billion reduction in market cap and a $31 billion drop in Zuckerberg’s personal net worth. Hello friends, and welcome back to Week in Review ! Image Credits: Facebook.

Marketing 246
article thumbnail

Odonate Therapeutics Prices IPO

socalTECH

San Diego-based Odonate Therapeutics , a pharmaceuticals startup focused on chemotherapy drugs, has priced its IPO, saying on Wednesday afternoon that it has priced its IPO at $24.00 per share was on the low end of its initial estimated pricing range of $24.00 The $24.00 READ MORE>>.

Pricing 113
article thumbnail

AnaptysBio Sets Estimated IPO Pricing Range

socalTECH

San Diego-based AnaptysBio , which develops antibodies for treating inflammation, has set its estimated IPO pricing range, saying on Tuesday that it expects to price its IPO at between $14.00 The company is selling 4,000,000 shares of its common stock on the NASDAQ Global Select Market as ANAB. and $16.00

Pricing 100
article thumbnail

Ambit Biosciences Prices IPO

socalTECH

San Diego-based Ambit Biosciences has priced its IPO, saying that it is offering up 8,125,000 shares of its common stock at $8.00 The company will start trading today on the NASDAQ Global Market as AMBI. Ambit priced well below its estimated initial public offering range, which had been set at between $13.00

Pricing 138
article thumbnail

Receptos Sets Estimated IPO Pricing Range

socalTECH

San Diego-based biopharmaceuticals developer Receptos has set the initial, estimated pricing range for its IPO, saying in a filing Thursday that it now expects its IPO pricing to be between $14.00 and $16.00 READ MORE>>. receptos merger acquisition lifescience biopharma biopharmaceuticals rcpt exit'

Pricing 153